Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric W. Jacobson
Eric W. Jacobson
Immunology
Diabetes mellitus
Crohn's disease
Medicine
Adverse effect
2
Papers
167
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
2010
Inflammatory Bowel Diseases
Bruce E. Sands
Eric W. Jacobson
Thomas Sylwestrowicz
Ziad Younes
Gerald W. Dryden
Richard N. Fedorak
Susan Greenbloom
Show All
Source
Cite
Save
Citations (71)
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
2006
Inflammatory Bowel Diseases
Robert Burakoff
Charles F. Barish
Dennis Riff
Ronald E. Pruitt
William Y. Chey
Francis A. Farraye
Ira Shafran
Seymour Katz
Charles L. Krone
Martha Vander Vliet
Christopher Stevens
Matthew L. Sherman
Eric W. Jacobson
Ronald Bleday
Show All
Source
Cite
Save
Citations (96)
1